Can-Fite BioPharma Ltd.
Income Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Revenue | $789.0K | $165.0K |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $5.1M | $6.1M |
| SG&A Expense | $2.9M | $2.7M |
| Operating Income | $-7.2M | $-8.7M |
| Operating Margin | -910.6% | -5,262.4% |
| Interest Expense | — | — |
| Pretax Income | $-6.4M | $-8.4M |
| Income Tax Expense | $29.0K | $29.0K |
| Net Income | $-6.3M | $8.3M |
| Net Margin | -803.4% | 5,004.2% |
| EPS (Basic) | — | — |
| EPS (Diluted) | — | — |
| Shares Outstanding (Basic) | 33.3M | — |
| Shares Outstanding (Diluted) | 33.3M | — |
| Dividends Per Share | — | — |